CC-486 and Venetoclax for Acute Myeloid Leukemia
Primary Objective
To determine the maximum tolerated or recommended dose of CC-486 in combination with venetoclax
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Lone Tree Medical Center
University of Colorado Hospital
Study ID
Protocol Number: 20-1319
More information available at ClinicalTrials.gov: NCT05287568
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers